建禹集團(08196.HK)2021年虧損1704.2萬元 同比收窄84.02%
格隆匯3月22日丨建禹集團(08196.HK)發佈公吿,截至2021年12月31日止年度,公司收益1.18億元人民幣,同比增加56.53%;期間虧損1704.2萬元,同比收窄84.02%;每股虧損0.06元。
於2021年,集團憑藉正常營運的項目,維持若干水平的現金流收入。在疫情防控的影響下,新建設項目無法如期或不間斷進行施工,而項目的成本,亦因疫情影響工期、環球物價通脹等因素而增加。儘管集團的收益及盈利能力表現欠佳,惟得益於本集團自2020年起應對疫情的經營考慮,集團營運規模及員工人數仍維持穩定,與2020年相比,亦有一定的改善。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.